Tove Øyjord

630 total citations
15 papers, 547 citations indexed

About

Tove Øyjord is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tove Øyjord has authored 15 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tove Øyjord's work include Cancer-related Molecular Pathways (4 papers), Cancer Genomics and Diagnostics (4 papers) and S100 Proteins and Annexins (4 papers). Tove Øyjord is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer Genomics and Diagnostics (4 papers) and S100 Proteins and Annexins (4 papers). Tove Øyjord collaborates with scholars based in Norway, Spain and United States. Tove Øyjord's co-authors include Øystein Fodstad, Gunhild M. Mælandsmo, Eivind Hovig, J. M. Nesland, R Holm, A-L Børresen, Viví Ann Flørenes, Olav Engebraaten, Ruth Holm and Christina Tekle and has published in prestigious journals such as Scientific Reports, Developmental Biology and British Journal of Cancer.

In The Last Decade

Tove Øyjord

15 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tove Øyjord Norway	9	350	268	143	142	108	15	547
Veronica R. Placencio United States	8	230 0.7×	354 1.3×	238 1.7×	212 1.5×	91 0.8×	13	666
Tae Sung Ahn South Korea	15	294 0.8×	255 1.0×	105 0.7×	119 0.8×	100 0.9×	45	602
Xuebing Di China	13	197 0.6×	355 1.3×	226 1.6×	175 1.2×	164 1.5×	24	700
Naoyuki Okabe Japan	15	392 1.1×	212 0.8×	197 1.4×	255 1.8×	173 1.6×	56	706
Chang-Long Chen China	14	357 1.0×	206 0.8×	130 0.9×	106 0.7×	220 2.0×	17	611
Juehui Liu United States	11	199 0.6×	400 1.5×	130 0.9×	178 1.3×	35 0.3×	11	628
Prashanth Prithviraj Australia	13	405 1.2×	319 1.2×	155 1.1×	193 1.4×	192 1.8×	28	753
Dan Lu China	9	203 0.6×	458 1.7×	131 0.9×	85 0.6×	76 0.7×	16	694
Satoshi Tsunetoh Japan	15	243 0.7×	280 1.0×	159 1.1×	67 0.5×	68 0.6×	32	715
Christian Britschgi Switzerland	17	413 1.2×	272 1.0×	101 0.7×	289 2.0×	145 1.3×	59	770

Countries citing papers authored by Tove Øyjord

Since Specialization

Citations

This map shows the geographic impact of Tove Øyjord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tove Øyjord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tove Øyjord more than expected).

Fields of papers citing papers by Tove Øyjord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tove Øyjord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tove Øyjord. The network helps show where Tove Øyjord may publish in the future.

Co-authorship network of co-authors of Tove Øyjord

This figure shows the co-authorship network connecting the top 25 collaborators of Tove Øyjord. A scholar is included among the top collaborators of Tove Øyjord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tove Øyjord. Tove Øyjord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Øyjord, Tove, Gunhild M. Mælandsmo, J.C. Angulo, et al.. (2024). Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma. OncoImmunology. 13(1). 2419686–2419686. 3 indexed citations

Nunes‐Xavier, Caroline E., Tove Øyjord, Gunhild M. Mælandsmo, et al.. (2023). The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. Scientific Reports. 13(1). 7339–7339. 7 indexed citations

Nunes‐Xavier, Caroline E., Tove Øyjord, Gorka Larrinaga, et al.. (2021). 76P B7-H3 immune checkpoint protein expression is associated with immune exhaustion, overall survival and metastasis in clear cell renal cell carcinoma. Annals of Oncology. 32. S1368–S1368. 1 indexed citations

Flem‐Karlsen, Karine, Christina Tekle, Tove Øyjord, et al.. (2019). p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance. Scientific Reports. 9(1). 5839–5839. 35 indexed citations

Nunes‐Xavier, Caroline E., Karine Flem‐Karlsen, Christina Tekle, et al.. (2016). Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors. Oncotarget. 7(6). 6891–6901. 75 indexed citations

Barkovskaya, Anna, Solveig Pettersen, Siver Andreas Moestue, et al.. (2015). Metabolic reprogramming supports the invasive phenotype in malignant melanoma. Cancer Letters. 366(1). 71–83. 67 indexed citations

Boye, Kjetil, Solveig Pettersen, Mads H. Haugen, et al.. (2015). Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes. Clinical & Experimental Metastasis. 32(8). 755–767. 11 indexed citations

Andersen, Kristin, Hidetoshi Mori, Jimmie E. Fata, et al.. (2011). The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis. Developmental Biology. 352(2). 181–190. 23 indexed citations

Andersen, Karin, et al.. (2010). 370 The metastasis-promoting protein, S100A4, regulates mammary branching morphogenesis. European Journal of Cancer Supplements. 8(5). 94–94. 1 indexed citations

10.

Graaf, Hiltje de, Gunhild M. Mælandsmo, Anne Forus, et al.. (1997). Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein geneEGP-2. International Journal of Cancer. 72(1). 191–196. 42 indexed citations

11.

Graaf, Hiltje de, Gunhild M. Mælandsmo, Anne Forus, et al.. (1997). Ectopic expression of target genes may represent an inherent limitation of RT‐PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP‐2. International Journal of Cancer. 72(1). 191–196. 2 indexed citations

12.

Mælandsmo, Gunhild M., Viví Ann Flørenes, Eivind Hovig, et al.. (1996). 散在性悪性黒色腫の発癌におけるpRb/p16/cdk4/サイクリンD1経路の関与. British Journal of Cancer. 73(8). 909–916. 4 indexed citations

13.

Mælandsmo, Gunhild M., Eivind Hovig, Tove Øyjord, et al.. (1996). Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. British Journal of Cancer. 73(8). 909–916. 96 indexed citations

14.

Øyjord, Tove, et al.. (1994). TP53 allele loss, mutations and expression in malignant melanoma. British Journal of Cancer. 69(2). 253–259. 59 indexed citations

15.

Andreassen, Åshild, Tove Øyjord, Eivind Hovig, et al.. (1993). p53 abnormalities in different subtypes of human sarcomas.. PubMed. 53(3). 468–71. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact